##common.pageHeaderLogo.altText##

Vol. 4 No. 3 (2024)

Aberrant Expression of Sprouty2 In Human Colon Cancer

Clinical Medicine And Health Research Journal, Vol. 4 No. 3 (2024), 26 June 2024 , Page 958-966
https://doi.org/10.18535/cmhrj.v4i3.364

Abstract

Purpose: The study investigates the role of Sprouty2 (SPRY2) in colorectal cancer (CRC) cell function. It found that SPRY2 inhibits the RAS/MAPK/ERK pathway and promotes cancer invasion in KRAS-WT CRC. However, it did not significantly alter p-ERK levels, cell proliferation, or invasion in KRAS-mutant CRCs. High SPRY2 expression was associated with shorter cancer-specific survival in both KRAS-WT and KRAS-mutant CRC patients. The study suggests that SPRY2 may promote invasion and progression in both types of CRC.


Methods: The gene expression data were retrieved from Gene Expression Omnibus (GEO). Fold change, p.value t-test and David Functional analysis, hierarchical clustering was performed.


Results: In this study, we identified altered genes involved in SPRY2 mutation in the colon and the relevant pathways to understand whether the SPRY2 mutation changes cancer progression. 4 genes of 5 genes were downregulated following the mutation in colon cancer cells. We identified a network between these genes and pathways they belong to. Pathway analysis showed that these genes are mostly associated with cancer cell proliferation.


Conclusion: MAL2, ESRP1, CDH3, CXCL14 and CDH1 genes were found to be associated with in SPRY2 mutation in colon cancer pathogenesis. Almost all these genes are effective in the proliferation of cancer cells, especially during the SPRY2 mutation process. Therefore, it is hypothesized that downregulation or upregulation of these genes may affect colon cancer pathogenesis by reducing cell proliferation. And it is predicted that SPRY2 mutation may be an important factor for colon cancer.

Keywords:
  • Sprouty-2
  • colon cancer
  • , receptor tyrosine kinase
  • RTK, receptor tyrosine kinase;

How to Cite

BAESMAT, A. S. ., & BAYRAKDAR, B. . (2024). Aberrant Expression of Sprouty2 In Human Colon Cancer. Clinical Medicine And Health Research Journal, 4(3), 958–966. https://doi.org/10.18535/cmhrj.v4i3.364

Download Citation

References

  • US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238. Erratum in: JAMA. 2021 Aug 24;326(8):773. PMID: 34003218.
  • Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015 Nov 5;1:15065. doi: 10.1038/nrdp.2015.65. PMID: 27189416; PMCID: PMC4874655.
  • Masoumi-Moghaddam S, Amini A, Morris DL. The developing story of Sprouty and cancer. Cancer Metastasis Rev. 2014 Sep;33(2-3):695-720. doi: 10.1007/s10555-014-9497-1. PMID: 24744103; PMCID: PMC4113681.
  • Holgren C, Dougherty U, Edwin F, Cerasi D, Taylor I, Fichera A, Joseph L, Bissonnette M, Khare S. Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas. Oncogene. 2010 Sep 23;29(38):5241-53. doi: 10.1038/onc.2010.264. Epub 2010 Jul 26. PMID: 20661223; PMCID: PMC2945447.
  • Ordóñez-Morán P, Irmisch A, Barbáchano A, Chicote I, Tenbaum S, Landolfi S, Tabernero J, Huelsken J, Muñoz A, Pálmer HG. SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer. Oncogene. 2014 Apr 10;33(15):1975-85. doi: 10.1038/onc.2013.140. Epub 2013 Apr 29. PMID: 23624922.
  • Feng YH, Wu CL, Tsao CJ, Chang JG, Lu PJ, Yeh KT, Uen YH, Lee JC, Shiau AL. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease. Cancer Biol Ther. 2011 Jan 1;11(1):111-21. doi: 10.4161/cbt.11.1.13965. Epub 2011 Jan 1. PMID: 21099344.
  • Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004 Jan-Feb;6(1):1-6. doi: 10.1016/s1476-5586(04)80047-2. PMID: 15068665; PMCID: PMC1635162.
  • Barbáchano A, Ordóñez-Morán P, García JM, Sánchez A, Pereira F, Larriba MJ, Martínez N, Hernández J, Landolfi S, Bonilla F, Pálmer HG, Rojas JM, Muñoz A. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene. 2010 Aug 26;29(34):4800-13. doi: 10.1038/onc.2010.225. Epub 2010 Jun 14. PMID: 20543868.
  • Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Ikeuchi H, Eshima K. Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways. Eur J Cancer. 2011 Sep;47(13):1946-54. doi: 10.1016/j.ejca.2011.03.029. Epub 2011 Apr 29. PMID: 21531130.
  • Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014 Jun;16(6):488-94. doi: 10.1038/ncb2976. PMID: 24875735.
  • Leeksma OC, Van Achterberg TA, Tsumura Y, Toshima J, Eldering E, Kroes WG, Mellink C, Spaargaren M, Mizuno K, Pannekoek H, de Vries CJ. Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. Eur J Biochem. 2002 May;269(10):2546-56. doi: 10.1046/j.1432-1033.2002.02921.x. PMID: 12027893.
  • Barbáchano A, Fernández-Barral A, Pereira F, Segura MF, Ordóñez-Morán P, Carrillo-de Santa Pau E, González-Sancho JM, Hanniford D, Martínez N, Costales-Carrera A, Real FX, Pálmer HG, Rojas JM, Hernando E, Muñoz A. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016 Jun 9;35(23):2991-3003. doi: 10.1038/onc.2015.366. Epub 2015 Oct 12. PMID: 26455323.
  • Kaszak I, Witkowska-Piłaszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of Cadherins in Cancer-A Review. Int J Mol Sci. 2020 Oct 15;21(20):7624. doi: 10.3390/ijms21207624. PMID: 33076339; PMCID: PMC7589192.
  • Samuelov L, Sprecher E, Tsuruta D, Bíró T, Kloepper JE, Paus R. P-cadherin regulates human hair growth and cycling via canonical Wnt signaling and transforming growth factor-β2. J Invest Dermatol. 2012 Oct;132(10):2332-2341. doi: 10.1038/jid.2012.171. Epub 2012 Jun 14. PMID: 22696062.
  • Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308. doi: 10.1155/2014/637308. Epub 2014 Aug 12. PMID: 25184143; PMCID: PMC4145387.
  • An L, Gong H, Yu X, Zhang W, Liu X, Yang X, Shu L, Liu J, Yang L. Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis. Cancer Cell Int. 2023 Jul 21;23(1):144. doi: 10.1186/s12935-023-02993-9. PMID: 37480012; PMCID: PMC10362617.
  • Vadlamudi Y, Dey DK, Kang SC. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT. Curr Cancer Drug Targets. 2020;20(9):654-665. doi: 10.2174/1568009620666200621153831. PMID: 32564755.
  • Wang Y, Wang S, Niu Y, Ma B, Li J. Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation. Int J Mol Sci. 2023 Nov 7;24(22):16027. doi: 10.3390/ijms242216027. PMID: 38003215; PMCID: PMC10671198.
  • Kouzeli A, Collins PJ, Metzemaekers M, Meyrath M, Szpakowska M, Artinger M, Struyf S, Proost P, Chevigne A, Legler DF, Eberl M, Moser B. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. Front Immunol. 2020 Oct 5;11:561404. doi: 10.3389/fimmu.2020.561404. PMID: 33123134; PMCID: PMC7570948.
  • Zhou L, Zhang Y, Wei M, Du K, Lin J, Wei L. Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer. BMC Gastroenterol. 2023 Aug 10;23(1):273. doi: 10.1186/s12876-023-02896-z. PMID: 37563546; PMCID: PMC10416425.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information